|
|
|
Saturday, February 26, 2011 — 7:00 p.m., CC 103 A/B
|
- Contemporary Issues in the Pathology of Bladder Carcinoma
|
|
Moderators:
|
Cristina Magi-Galluzzi, Cleveland Clinic, Cleveland, OH and
Kiril Trpkov, University of Calgary, Calgary, AB, Canada
|
|
|
Disclosure:
|
In accordance with ACCME guidelines regarding disclosure, the USCAP policy requires that faculty members who have a significant financial or other relationship with a commercial company, entity, or service (which will be discussed in this Symposium) must disclose this to attendees. The Academy also requires that speakers disclose any products that are not labeled for the use under discussion. The speakers listed below have indicated they have nothing to disclose.
|
Click the button above to add this event to your Itinerary Planner...
| 7:00 | Introduction and President's Remarks
- John Srigley, McMaster University, Hamilton, ON, Canada |
| 7:15 | Practical Issues in Diagnosis, Grading, and Staging of Urothelial Carcinoma
- Mahul Amin, Cedars-Sinai Medical Center, Los Angeles, CA |
| 7:50 | The Diverse Morphological Faces of Carcinoma of Urinary Bladder
- Antonio Lopez-Beltran, Univeristy Hospital of Cordoba,
Cordoba, Spain |
| 8:25 | Tumor-Like Lesions and Benign Histologic Mimickers of Bladder Carcinoma
- Esther Oliva - Massachusetts General Hospital, Boston, MA |
| 9:00 | The Molecular Pathology of Bladder Carcinoma and Future Perspectives
- George Netto, Johns Hopkins University Hospital, Baltimore, MD |
The topics for the symposium were determined by the President in consultation with the Executive Committee and the Annual Meeting Program Committee representing the general membership. The selection of topics takes into consideration previous companion meeting presentations, the needs of our society members and the general audience and the recent developments in the field of genitourinary pathology.
The current program aims to transfer knowledge related to important and timely topics in urinary bladder pathology and also to provide a better understanding of diagnostic criteria and pathogenesis of urothelial neoplasia. In each presentation there will be a discussion of pathological findings and recent scientific developments related to several aspects of bladder carcinoma. This will allow for improved accuracy in diagnosis and prognosis of bladder tumors.
The current program will cover recent advances and developments in relationship to the diagnosis, grading, staging, and reporting of bladder specimens and will provide guidelines to improve cancer pathology practice. Other topics will provide a specific updates on the classification of bladder carcinoma including diverse rare variants, histological mimickers of bladder carcinoma and recent developments in molecular pathology of urothelial neoplasia. |
|
|
|
